Recently, in a mouse model of proliferative retinopathy, Chen et al. studied the role of EPO in suppression of retinal neovascularization; they proposed the hypothetic intravitreal use of EPO in proliferative retinopathy [28]. Here, EPO is linked to retinal disorder.